Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Dear teacher, this is how I spent my summer vacation…
. An interest and appetite for science appears to be alive and well in two jurisdictions where high school students competed for the chance to spend part, or all, of their summer learning about stem cells and biomedical research. The winners of a science animation festival spent one week at the Institute of Biomaterials and […]
Right Turn: Like a kid’s science show, but for grownups
. Jordan Green, a biomedical engineer from Johns Hopkins, has a way with words. And toys. He’s like a Mister Rogers (American) or Mr. Dressup (Canadian) for adults. He has a complicated idea to convey, so borrowing from the best children’s entertainers around, he uses colourful props that perfectly suit his friendly demeanor. Dr. Green’s […]
Right Turn: Stem Cell Diabetes Treatment Looking Sweet
. It’s nice to end the week on a happy note. For a company like CCRM that commercializes regenerative medicine products and therapies, the news that ViaCyte, a company based in San Diego, California, has applied to the FDA to start clinical trials for its Type 1 diabetes treatment is good news for the industry. […]
Stifling Science?
On June 18, 2014, I walked into the enormous, blue lit plenary hall of the Vancouver Convention Centre excited to hear Canada’s own Janet Rossant give the opening remarks for ISSCR’s Presidential Symposium. I glanced up at the information screens and read, to my dismay, “no live tweeting from the conference.” So what’s a […]